Managers

Golub's Peter Fair on the SaaS report: `More seed is good'

JDRF T1D Fund appoints Ellias as managing director

The JDRF T1D Fund, a venture philanthropy fund focused on type 1 diabetes, has named Katie Ellias as managing director. Previously, Ellias worked at Endeavour Vision where she was a senior investment director.

Primary care app K Health inks $12.5 mln

New York-based K Health, a primary care app, has raised $12.5 million in financing. The investors were Mangrove Capital Partners, Lerer Hippeau, Primary Venture Partners, BoxGroup, Max Ventures, Bessemer Venture Partners and Comcast Ventures.

Rubius Therapeutics goes public

Cambridge, Massachusetts-based Rubius Therapeutics, a creator of cellular therapies, has debuted its IPO after pricing its over 10.4 million shares at $23 per share. The stock began trading July 18, 2018 on the NASDAQ under the ticker symbol "RUBY." J.P. Morgan, Morgan Stanley, Jefferies and Leerink Partners are the lead underwriters. Rubius' pre-IPO backers include Flagship Pioneering.

Centivo snags $34 mln Series A

Centivo, a new type of self-funded health plan, has raised $34 million in Series A funding. Bain Capital Ventures led the round with participation from other investors that included from F-Prime Capital Partners, Maverick Ventures, Bessemer Venture Partners, Ingleside Investors, Rand Capital, Grand Central Tech Ventures and Oxeon Investments.

Greycroft closes fifth fund at $250 mln

Greycroft has raised $250 million for its fifth fund. As with its previous funds, Greycroft will focus on B2B and B2C internet and mobile companies.

Louisiana Teachers' commits $175 mln to Blackstone, TCV, TPG

Tenable’s IPO may be a cybersecurity unicorn in the making

VCs on the Move, monthly recap as of July 17

New Voices Fund raises $20 mln for $100 mln-targeted fund

New Voices Fund has raised $20 million for its new fund, according to an SEC filing. The target is $100 million. The fund will focus on women of color entrepreneurs.